MedTrace Logo

A First Time in Man Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1979 in Healthy Males

NCT02072993 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2014-07-29

No results posted yet for this study

Summary

This is a first time in human study to assess the safety and tolerability of AZD1979 following oral administration of single ascending doses in healthy male volunteers. Pharmacokinetics (what the body does to the drug) parameters will also be assessed as secondary objectives.

Conditions

  • Healthy Subjects

Interventions

DRUG

AZD1979

Single dose, oral solution administration

DRUG

Placebo to match

Single dose, oral solution administration

Sponsors & Collaborators

Principal Investigators

  • Eleanor Lisbon, MD · Quintiles 6700 W 115th Street, Overland Park, KS USA

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02072993 on ClinicalTrials.gov